Exploring Siglec-6 as a novel target for potential therapeutic utility in chronic lymphocytic leukemia

Speaker(s)

• NM

  Natarajan (Raj) Muthusamy, DVM, PhD

  Professor of Medicine
  The Ohio State University
  Columbus, Ohio, United States